SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-214900
Filing Date
2020-08-10
Accepted
2020-08-10 16:02:51
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d19243d10q.htm   iXBRL 10-Q 1425732
2 EX-31.1 d19243dex311.htm EX-31.1 10315
3 EX-31.2 d19243dex312.htm EX-31.2 10251
4 EX-32.1 d19243dex321.htm EX-32.1 5170
  Complete submission text file 0001193125-20-214900.txt   5550333

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cbay-20200630.xsd EX-101.SCH 30721
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20200630_cal.xml EX-101.CAL 35524
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20200630_def.xml EX-101.DEF 145443
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20200630_lab.xml EX-101.LAB 278781
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20200630_pre.xml EX-101.PRE 216824
10 EXTRACTED XBRL INSTANCE DOCUMENT d19243d10q_htm.xml XML 1095438
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 201089276
SIC: 2834 Pharmaceutical Preparations